Opendata, web and dolomites

SUPAIR Spectroscopy

SUPAIR Spectroscopy: Single-Use Process Analytical Infrared Spectroscopy

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SUPAIR Spectroscopy project word cloud

Explore the words cloud of the SUPAIR Spectroscopy project. It provides you a very rough idea of what is the project "SUPAIR Spectroscopy" about.

business    sme    2025    roadmap    analytical    mammalian    compact    bioreactors    commercial    200    streams    expensive    cells    team    feasibility    atr    quality    savings    mir    half    efficiency    price    spectrometer    direct    usually    fourier    complete    promoted    techniques    automated    biologic    flow    medical    read    technologies    poised    award    single    affordable    carry    impressive    customers    spectroscopy    total    sub    water    drugs    biopharma    b2b    150    probes    mid    monitoring    time    irubis    attenuated    revenue    sensors    cell    companies    optimal    consumption    solution    performed    sterilization    distributors    reused    accelerator    reactors    exist    company    render    billion    pending    valley    costing    requiring    competing    500    biopharmaceutical    silicon    energy    transform    industry    offers    merits    patent    solutions    first    reflectance    awarded    300    consecutive    sales    crystal    cultivating    monitored    size    scholarship    model    optical    online    infrared    flexible    ftir    market    innovation    merck    eliminates    pat   

Project "SUPAIR Spectroscopy" data sheet

The following table provides information about the project.

Coordinator
IRUBIS GMBH 

Organization address
address: SCHILLERSTRASSE 40 B
city: MUNCHEN
postcode: 80336
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Project website https://irubis.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-05-01   to  2019-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    IRUBIS GMBH DE (MUNCHEN) coordinator 50˙000.00

Map

 Project objective

The biopharmaceutical industry is poised to reach an impressive market size of more than €300 billion by 2025. The production of biologic drugs is usually performed by cultivating mammalian cells within bioreactors. Those reactors are increasingly being monitored online by means of Process Analytical Technologies (PAT). However state-of-the-art techniques render both sub-optimal product quality and product efficiency. A complete mid-infrared (MIR) spectroscopy system using online Attenuated Total Reflectance (ATR) probes is highly expensive costing around €200,000, €20,000 only for the probes that are not robust enough, requiring consecutive sterilization to be reused (raising water and energy consumption). IRUBIS GmbH team goal is to make online monitoring of (single-use) bioreactors affordable. IRUBIS innovation comprises a single-use patent-pending silicon ATR crystal integrated in a single-use ATR Flow Cell which is read out by a compact Fourier Transform Infrared (FTIR) Spectrometer. IRUBIS Analytical Technology offers a system that will allow for the first time real-time process control (online) in single-use bioreactors. This means a flexible, highly automated system solution that costs half the price of the competing solutions. Furthermore, it eliminates sterilization requirements allowing for important energy savings. IRUBIS has been awarded an accelerator program promoted by Merck; Company recent merits also include the Medical valley award (€500,000) and the Exist scholarship (€150,000). Our business model will be based in two revenue streams: B2B direct sales of developed IRUBIS optical sensors to biopharma companies and sales through partnerships with distributors. The feasibility study we will carry out under this SME Phase 1 project, will define the technical, market and commercial roadmap allowing to offer customers a higher value product.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SUPAIR SPECTROSCOPY" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SUPAIR SPECTROSCOPY" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Magnesys (2019)

Efficient filtering of metallic impurities in food processing

Read More  

PhantoMinds (2019)

Better and faster innovations with PhantoMinds’ instant automated recruiting tool for open innovators

Read More  

SCAT (2019)

Smart Composites for Additive Technology

Read More